Steve Heath of Medidata Solutions takes a look at electronic data capture solutions.
A new imaging agent, 64*Cu-DOTA-bevacizumab, has been developed for scanning of tumour growth and functional imaging of angiogenesis in animal tumour models.
Membrane proteins are hard to handle. Deadlines are constantly broken, research budgets stretched to the limit and not to mention the overall general frustration.
Assay development services from Olink Bioscience for research into proteins and their interactions in cells, tissues and somatic fluids